1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Geratherm Medical AG

Geratherm Medical AG

GME.DE
Geratherm Medical AGDE flagDeutsche Börse
2.73
EUR
- -
- -
14.77MMarket Cap
Geratherm Medical AG
GME.DE
(Deutsche Börse)

Recent

price

2.73

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3.59
3.54
3.29
3.44
3.96
4.5
4.46
4.34
4.41
4.11
5.67
4.98
5.04
4.12
2.66
2.96
4.97
Revenue per Share
0.51
0.29
0.24
0.27
0.34
0.55
0.45
0.14
0.19
0.11
0.41
0.02
0.19
0.21
0.13
-0.15
0.19
Basic EPS, GAAP
-0.16
-0.16
0.16
0.38
0.04
0.6
-0.26
0.19
-0.66
-0.29
0.23
0.04
0.01
-0.03
0.23
0.13
0.4
Free Cash Flow per Basic Share
0.4
0.4
0.3
0.2
0.24
0.25
0.5
0.5
0.47
0.4
0.25
0.4
0.12
0.15
0.1
0.1
- -
Dividend per Share
1
1
1
1
1
1
1
1
1
1
1.26
0.81
0.88
0.93
0.96
0.71
0.87
Book Value per Share
3.99
3.66
3.65
3.92
3.96
4.31
4.03
3.99
3.64
3.43
3.4
2.81
3.31
3.32
3.55
3.27
3.26
Tangible Book Value per Share
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
6
Basic Weighted Avg Shares
18
18
16
17
20
22
22
21
22
20
28
25
27
22
14
16
27
Sales/Revenue/Turnover
13.22
11.63
7.34
6.84
13
14.85
12.15
6.01
9.57
5.78
13.8
3.51
11.12
14.28
-29.46
-0.38
11.12
Operating Margin (%)
1
1
1
1
1
1
1
1
1
1
1
2
1
2
2
1
1
Depreciation Expense
3
1
1
1
2
3
2
1
1
1
2
- -
1
1
1
-1
1
Net Income, GAAP
23.74
40.68
20.49
11.44
28.73
28.14
23.29
52.04
58.75
72.07
30
- -
36.39
27.77
32.16
- -
36.39
Effective Tax Rate (%)
14.3
8.28
7.34
7.83
8.58
12.14
10.14
3.16
4.25
2.68
7.29
0.5
3.73
4.98
4.89
-5.11
3.73
Profit Margin (%)
17
15
18
19
19
20
18
19
13
14
14
17
21
11
15
13
21
Working Capital
2
2
4
4
3
2
2
3
2
5
7
8
9
4
2
1
9
LT Debt
21
19
19
20
20
22
21
21
20
19
20
18
22
23
21
19
22
Total Equity
8.12
5.29
4.08
4.09
7.09
9.23
8.17
2.57
3.64
1.29
9.3
- -
6.31
6.95
4.04
- -
6.31
Return on Invested Capital (%)
33.12
24.01
14.93
17.13
20.41
37.19
34.01
17.76
18.86
8.57
16.76
- -
7.3
4.37
6.69
- -
7.3
Return on Capital (%)
53.81
29.31
24.13
26.95
33.99
54.57
45.19
13.73
18.77
11.02
36.63
2.39
23.3
22.62
13.75
-18.08
23.3
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
ST Debt
4
4
- -
LT Borrowings
5
6
9
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
41
30
28

Working Capital

FRC

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
Total Current Assets
24
24
24
Cash, Cash Equivalents & STI
11
10
11
Accounts Receivable, Net
4
4
4
Inventories
8
8
8
Total Current Liabilities
10
11
2
Payables & Accruals
- -
- -
- -
ST Debt
4
4
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.83%
0.17%
-6.61%
Free Cash Flow
-248.56%
-297.83%
-41.92%
Net Income, GAAP
58.26%
79.83%
-216.14%
Sales/Revenue/Turnover
-1.44%
-8.75%
11.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
22
2024
- -
- -
- -
- -
14
2025
- -
- -
- -
- -
16

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.21
2024
- -
- -
- -
- -
0.13
2025
- -
- -
- -
- -
-0.15

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.15
2024
- -
- -
- -
- -
0.1
2025
- -
- -
- -
- -
0.1
Similar Companies
Siemens Healthineers AG (SEMHF)
ResMed Inc. (RSMDF)
Integra LifeSciences Holdings Corporation (IART)
PolyNovo Limited (PNV.AX)
Atomo Diagnostics Limited (AT1.AX)
STRATA Skin Sciences, Inc. (SSKN)
Business
Geratherm Medical AG develops, manufactures and distributes medical technology products focused on temperature management, diagnostics and respiratory care; its core offerings encompass analog and digital clinical thermometers under the renowned Geratherm brand with over 120 years of tradition in glass production, blood pressure monitors, inhalers, rapid tests for women's health including natural family planning and oxygen measurement solutions, spirometry and pulmonary function testing devices such as Spirostik Blueflow, and incubator systems for neonatal care. The company operates through segments including Healthcare Diagnostics, Respiratory and Incubator Systems, serving end consumers in home care as well as professionals in clinics, practices and rehabilitation facilities worldwide; it exports 82% of production to over 60 countries from five production sites in Germany and a sales office in Brazil. Founded in 1993 from predecessors dating to 1900 and headquartered in Geratal-Geschwenda, Thuringia, Germany, Geratherm Medical AG lists on the Frankfurt Stock Exchange under ticker GME.DE and maintains subsidiaries in pulmonary function diagnostics via Geratherm Respiratory GmbH, stroke prevention through apoplex medical technologies GmbH prior to divestment, glass production and manufacturing including Capillary Solutions established in 2016, alongside an in-house glass melting plant opened in 2019. Recent strategic realignments include the September 2024 sale of its 60.55% stake in apoplex medical technologies GmbH to a German-American consortium for approximately EUR 16.5 million, enhancing balance sheet strength with net liquidity rising over EUR 7 million by fiscal year-end 2024; in October 2024, it acquired a 20% minority stake in BIOThermare GmbH, a manufacturer of innovative cold/warm compresses with patented seaweed gel, assuming partial international distribution rights; additionally, the company launched technical solutions to mitigate supplier dependencies in respiratory products and extended short-time work at its Geratal clinical thermometer site through December 2025 amid market softness, while reporting 30% Respiratory segment growth and projecting substantial fiscal 2025 revenue rebound.